UNSPSC 51294908: Aceprometazine maleate

This classification denotes the maleate form of an antidepressant agent with the molecular formula C19H22N2OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 984N9YTM4Y, chemically known as ketone, 10-(2-(dimethylamino)propyl)phenothiazin-2-yl methyl but more generally known as aceprometazine, which bears US NIH Compound Identifier 26035. European Medicines Agency schedules Aceprometazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05214MIG.

UNSPSC 51294908 Aceprometazine maleate is a Commodity code that captures pharmaceutical products procured by state and local public health agencies, though recent solicitation activity under this specific code appears sparse. The source reflects little current buying activity tagged directly to this aceprometazine maleate code, and the one recent opportunity posted does not align with the code's nominal scope — Seminole County, Florida posted an IFB for naloxone and drug deactivation systems, which represent different pharmaceutical commodities entirely. When state and local procurement offices tag opportunities with pharmaceutical codes, the work typically involves purchase, storage, and quarterly or on-demand delivery of controlled or emergency-use medications to health departments, community health centers, or emergency services; however, this particular code's recent activity does not substantiate that pattern.

Seminole County, Florida is the only issuing body reflected in recent opportunities, posting IFB 60459723LAS on June 30, 2026 with a response deadline of July 26, 2023 (noting an apparent date inconsistency in the source record). The county sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, requiring E-Verify compliance, workers' compensation and general liability insurance, and potential FEMA funding with associated federal regulatory adherence. The mismatch between the code's stated commodity and the actual solicitation suggests either miscoding or minimal recent procurement under aceprometazine maleate specifically. Firms pursuing pharmaceutical supply contracts with state and local health agencies should verify code alignment with issuing bodies before bid preparation, as tagging errors may limit visibility into genuine buying activity in this space.